Dr Sarah Hargreaves was appointed Consultant Clinical Oncologist at University Hospitals Bristol and Weston NHS Foundation Trust in October 2021, specialising in Head and Neck and HPB cancers.

Prior to taking a consultant post, Sarah completed a 3 year Clinical Research Fellowship at Velindre Cancer Centre in Cardiff, and was involved in setting up the PEARL study, looking at biological response based adaptive radiotherapy in HPV positive OPSCC. Sarah was awarded an MD at Cardiff University earlier this year.

Sarah graduated from Oxford University with a First Class Honours degree in Physiological Sciences before completing her undergraduate medical degree at Guy’s, Kings and St Thomas’s Medical School, London. She remained in London for the majority of her training, interspersing it with jobs in New Zealand and Tanzania, before moving to Bristol for the final three years of her Clinical Oncology training.

Sarah is currently an NIHR award holder, and Honorary Senior Lecturer at Bristol University. She is Oncology lead for the Head and Neck 5000 study. Her research interests include head and neck palliative radiotherapy, long term radiotoxicity and patient reported outcomes, and the improvement in equity of access to clinical studies. She lives in Bristol with her husband and two young sons.